However, due to dual effect of B7-H4 in the cellular immune response, further research is needed to explore whether modulating the acetylation/deacetylation process of B7-H4 can produce a specific therapeutic effect in cancer immunotherapy. This evidence concerns the gene VTCN1 and cancer.